A Phase 1, Randomized, Open-Label, Crossover Study to Evaluate the Relative Oral Bioavailability of 2 Formulations of PTC923 and the Food Effect on the Phase 3 Formulation When Administered as a Single Dose to Healthy Subjects
Latest Information Update: 04 Apr 2022
At a glance
- Drugs Sepiapterin (Primary)
- Indications Phenylketonuria
- Focus Pharmacokinetics
- Sponsors Incline Therapeutics; PTC Therapeutics
Most Recent Events
- 04 Apr 2022 New trial record